About Technology Issues FAQ

Links

Official Page

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.